MTOR inhibitors in the treatment of endocrine tumors
- 专利权人:
- NOVARTIS AG
- 发明人:
- MARKS, PETER WAYNE,LEBWOHL, DAVID
- 申请号:
- ES10175197
- 公开号:
- ES2481671T3
- 申请日:
- 2006.11.20
- 申请国别(地区):
- ES
- 年份:
- 2014
- 代理人:
- 摘要:
- 40-O- (2-hydroxyethyl) -rapamycin for use in a treatment of a pancreatic neuroendocrine tumor.40-O-(2-hidroxietil)-rapamicina para el uso en un tratamiento de un tumor neuroendocrino pancreático.
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- TREATING NEUROENDOCRINE TUMOURS
- Methods of treating epithelioid cell tumors
- MEDIUM COMPOSITION FOR INHIBITING SENESCENCE OF CARDIAC PROGENITOR CELLS CONTAINING RAPAMYCIN
- mTOR/STAT3 Mesenchymal stem cells treated mTOR/STAT3 signaling inhibitor having immuno-modulating activity and cell therapeutic agent for preventing or treating immune disease
- 암의 처치를 위한 이노투즈맙 오조가미신 및 토리셀의 조합